Mariner, LLC Veru Inc. Transaction History

Mariner, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.72 - $1.33 $8,392 - $15,502	-11,656 Reduced 27.4%	30,890 $22,000
Q2 2023 Aug 11, 2023	SELL	$0.98 - $1.49 $9,056 - $13,769	-9,241 Reduced 17.84%	42,546 $50,000
Q1 2023 May 12, 2023	BUY	$1.16 - $6.41 $21,136 - $116,796	18,221 Added 54.28%	51,787 $60,000
Q4 2022 Feb 14, 2023	BUY	$4.78 - $15.01 $15,095 - $47,401	3,158 Added 10.39%	33,566 $177,000
Q3 2022 Nov 10, 2022	BUY	$10.22 - $23.7 $13,020 - $30,193	1,274 Added 4.37%	30,408 $350,000
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $126,732 - $461,773	29,134 New	29,134 $330,000
Q2 2021 Aug 24, 2021	SELL	$7.24 - $11.2 $144,800 - $224,000	-20,000 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$8.05 - $20.78 $115,106 - $297,133	-14,299 Reduced 41.69%	20,000 $216,000
Q4 2020 Feb 16, 2021	BUY	$2.36 - $9.99 $80,945 - $342,647	34,299 New	34,299 $297,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.